Question

A 61-year-old with T2D and eGFR 62 asks about ACEi/ARB plus SGLT2i on potassium. What is key?

Accepted Answer

Monitor K+ and renal function regularly due to hyperkalemia risk with RAAS blockade and small creatinine rise with SGLT2i initiation

Answer

No monitoring needed

Answer

Stop ACEi if creatinine rises any amount

Answer

SGLT2i increase K+ markedly

Answer

Monitoring lipids only is required

Practice question

A 61-year-old with T2D and eGFR 62 asks about ACEi/ARB plus SGLT2i on potassium. What is key?